The Chennai based, Arvind Remedies Limited is setting up a world-class facility near Chennai to take up manufacturing of tablets, injectibles and soft gelatin capsules.

The facility will confirm to the US FDA and UK MCA Standards and will involve an investment of Rs.50 Crore. The facility will be operational by 2003 adn will be funded through term loans and internal accruals. The company also intends to re-focus the therapeutic segments it will be present in and is looking at endochronology, dermatology, cardiovascular diseases and nutrition as the new focus areas and intends to launch newer products over the next year. These segments would contribute to 30 percent of the turnover in future.

The company is already present in pediatrics, pain management, gynaecology and diabities segment, which together contribute around 60 percent of the company's total turnover.

Currently, allopathic medicines contribute around 70 percent of the total revenues of Arvind Remedies, and the balance comes from ayurvedic medicines. The company is also planning to launch a number of novel nutritional products to increase its range.

"Our focus area in future will be marketting our ayurveda products in the domestic and international markets " managing director and CEO, Arvind Remedies Limited, Arvind Shah told The Financial Express.

The company has already developed speciality ayurvedic products - 'Pankare' , which is a holistic drug for diabities.

"The product is based on herbal formulation as enunciated in ayurveda, which is a comprehensive combination of nine sanjeevinies and offer restoration, regeration and rejuvination of pancreatic beta cells, " Mr Shah added.

"Pankare is the outcome of our research and development activities in ayurveda adn is a unique formulation in the management of diabities, " he added.